Elizabeth M. Feijen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Risk Factors for Valvulopathy Among Childhood Cancer Survivors.

Risk Factors for Valvulopathy Among Childhood Cancer Survivors.

Journal: JAMA oncology
Published: October 09, 2025

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY Study.

Early Detection of Acute and Early-Onset Cancer Therapy-Related Cardiac Dysfunction in Children With Cancer Using a Multiparametric Approach: Methodological Aspects of the EARLY Study.

Journal: Cancer medicine
Published: July 25, 2025

IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.

IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.

Journal: JACC. CardioOncology
Published: March 19, 2025

Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors.

Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors.

Journal: The Lancet. Oncology
Published: December 24, 2023

Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors.

Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors.

Journal: Heart (British Cardiac Society)
Published: September 21, 2023

Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study.

Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study.

Journal: Cancer
Published: July 18, 2023

Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Comment on: Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane.

Journal: Pediatric blood & cancer
Published: July 14, 2023

A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors.

A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors.

Journal: JACC. CardioOncology
Published: July 06, 2023

The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.

The cumulative burden of self-reported, clinically relevant outcomes in long-term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study.

Journal: Cancer
Published: May 30, 2023

Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review.

Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review.

Journal: BMC cancer
Published: May 27, 2023

Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study.

Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 26, 2023

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.

BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.

Journal: Blood
Published: May 16, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026